What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Immune system
- Antibody
Her main research concerns Immunology, Antibody, Monoclonal antibody, IL-2 receptor and Internal medicine.
Her research is interdisciplinary, bridging the disciplines of Nod and Immunology.
She interconnects Transplantation and Kidney transplantation in the investigation of issues within Antibody.
Lucienne Chatenoud has researched Monoclonal antibody in several fields, including Azathioprine, Indirect immunofluorescence and Pathology.
Her studies in IL-2 receptor integrate themes in fields like Immune tolerance and FOXP3.
Her Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Surgery.
Her most cited work include:
- Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (956 citations)
- Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice (573 citations)
- TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes (563 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Monoclonal antibody, Immune system, Antibody and Transplantation.
Her work is connected to Immune tolerance, Autoimmunity, T cell, NOD mice and Immunosuppression, as a part of Immunology.
Her Autoimmunity research is multidisciplinary, incorporating elements of Type 1 diabetes and Organ transplantation.
In her research, Interferon gamma is intimately related to Tumor necrosis factor alpha, which falls under the overarching field of Monoclonal antibody.
Her research integrates issues of Autoimmune disease and Antigen in her study of Immune system.
She combines subjects such as Gastroenterology, Islet, Kidney and Immunotherapy with her study of Transplantation.
She most often published in these fields:
- Immunology (103.18%)
- Monoclonal antibody (23.89%)
- Immune system (31.85%)
What were the highlights of her more recent work (between 2012-2021)?
- Immunology (103.18%)
- Immune system (31.85%)
- Antibody (27.71%)
In recent papers she was focusing on the following fields of study:
Lucienne Chatenoud spends much of her time researching Immunology, Immune system, Antibody, Cytotoxic T cell and Type 1 diabetes.
Her work on Transplantation expands to the thematically related Immunology.
Her Immune system study combines topics from a wide range of disciplines, such as Pathogenesis, Disease, Cell therapy and Antigen.
Her research in Antibody intersects with topics in CD3 and B-1 cell.
Her Cytotoxic T cell research includes themes of Peripheral tolerance, Cancer research and Clonal anergy.
The Type 1 diabetes study combines topics in areas such as Teplizumab, Otelixizumab and Immunotherapy.
Between 2012 and 2021, her most popular works were:
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
- Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. (128 citations)
- Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. (128 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Internal medicine
- Antibody
Immunology, Antibody, Immune tolerance, Transplantation and Immune system are her primary areas of study.
Her biological study spans a wide range of topics, including Type 1 diabetes and Cancer research.
Her work deals with themes such as Surgery, Antigen, Kidney, Etiology and Donor specific antibodies, which intersect with Antibody.
Her work carried out in the field of Immune tolerance brings together such families of science as Cytotoxic T cell, Granzyme B, TGF beta signaling pathway and Autoimmunity.
Her study in Transplantation is interdisciplinary in nature, drawing from both Urology, Naive B cell, Human leukocyte antigen and Renal function.
The Immune system study which covers Cell therapy that intersects with Spleen, Combination therapy, Islet and T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
